首页> 美国卫生研究院文献>The Journal of Clinical and Aesthetic Dermatology >Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5 Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

【2h】

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5 Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

机译：开放标签扩展研究评估FMX103 1.5％米诺环素局部泡沫的长期安全性和疗效用于治疗中度至重度突出的椎间露菌瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 The Journal of Clinical and Aesthetic Dermatology
作者
Linda Stein Gold; James Q. Del Rosso; Leon Kircik; Neal D. Bhatia; Deirdre Hooper; Walter Nahm; Iain Stuart;
展开▼
作者单位

展开▼
年(卷),期 2020(13),11
年度 2020
页码 44–49
总页数 6
原文格式 PDF
正文语种
中图分类皮肤病学与性病学;
关键词
minocycline; open-label; papulopustular rosacea; phase 3 clinical trial; safety; topical therapy;

机译：米诺霉素;开放标签;椎间盘突出的酒渣鼻;第3期临床试验;安全;局部治疗;

相似文献

外文文献
中文文献
专利

1. Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea [J] . Linda Stein Gold, James Q. Del Rosso, Leon Kircik, The Journal of Clinical and Aesthetic Dermatology . 2020,第11期

机译：开放标签扩展性研究评估FMX103 1.5％米诺环素局部泡沫的长期安全性和疗效，用于治疗中度至重度椎弓原
2. Safety and Pharmacokinetics of FMX103 (1.5% Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions [J] . Terry M. Jones, Iain Stuart The Journal of Clinical and Aesthetic Dermatology . 2021,第3期

机译：在最大用处理条件下，具有中度至重度椎间露菌瘤的受试者的FMX103（1.5％米诺辛杂环液）的安全性和药代动力学
3. A Phase II, Randomized, Double-Blind Clinical Study Evaluating the Safety, Tolerability, and Efficacy of a Topical Minocycline Foam, FMX103, for the Treatment of Facial Papulopustular Rosacea [J] . Mrowietz Ulrich, Kedem Tal Hetzroni, Keynan Rita, American journal of clinical dermatology . 2018,第3期

机译：II期，随机的双盲临床研究评估局部米诺环素泡沫，FMX103的安全性，耐受性和功效，用于治疗面部椎平面的面疙瘩Rosacea
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Safety and Pharmacokinetics of FMX103 (1.5 Minocycline Topical Foam) in Subjects with Moderate-to-Severe Papulopustular Rosacea under Maximum-use Treatment Conditions [O] . Terry M. Jones, Iain Stuart 2021

机译：在最大限度使用处理条件下在中度至重度椎间油术机制中的FMX103（1.5％米诺里氏素局部泡沫）的安全性和药代动力学
7. Open-Label Extension Study Evaluating the Long-Term Safety, Efficacy, and Tolerability of FMX103 1.5 Topical Minocycline Foam in the Treatment of Moderate-to-Severe Facial Papulopustular Rosacea [O] . Linda Stein Gold, James Del Rosso, Leon Kircik, 2020

机译：开放标签扩展研究评估FMX103 1.5％局部含米诺环素泡沫的长期安全性，疗效和耐受性，治疗中度至严重的面部椎骨软缺程

Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5 Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea

著录项

相似文献

相关主题

期刊订阅